Association study on the DLG4 gene and schizophrenia in the Chinese Han population

Psychiatric Genetics

Volumn 23, Issue 6, 2013, Pages 247-250

  Li, Xing Wang ^a,c   Liu, Bao Cheng ^a,c   Wang, Yang ^a,c   Zhao, Qing Zhu ^a,c   Shen, Qi ^a,c   Yu, Tao ^a,c   Chen, Shi Qing ^a,c   Yang, Feng Ping ^a,c   Li, Wei Dong ^a,c   Gao, Ling Han ^a,c   Xu, Yi Feng ^d   Feng, Guo Yin ^d   He, Lin ^a,b,c   He, Guang ^a,c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c Chinese Academy of Sciences   (China)

^d SHANGHAI MENTAL HEALTH CENTER   (China)

Author keywords

association study; case control; DLG4; PSD 95; schizophrenia

Indexed keywords

DISC LARGE HOMOLOG 4 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARANOIA; POSITIVE SYNDROME; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; ETHNIC GROUPS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LINKAGE DISEQUILIBRIUM; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 84887106609     PISSN: 09558829     EISSN: 14735873     Source Type: Journal    
DOI: 10.1097/YPG.0b013e3283643671     Document Type: Article

References (31)

1. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders. Washington: American Psychiatric Press.
2. Barrett JC, Fry B, Maller J, Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
3. Cheng MC, Lu CL, Luu SU, Tsai HM, Hsu SH, Chen TT, Chen CH (2010). Genetic and functional analysis of the DLG4 gene encoding the postsynaptic density protein 95 in schizophrenia. PLoS One 5: e15107.
4. Coyle JT, Tsai G (2004). The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia. Psychopharmacology (Berl) 174: 32-38.
5. Fanous AH, Kendler KS (2008). Genetics of clinical features and subtypes of schizophrenia: a review of the recent literature. Curr Psychiatry Rep 10: 164-170.
6. Faul F, Erdfelder E, Lang AG, Buchner A (2007). GPower 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39: 175-191.
7. Feyder M, Karlsson RM, Mathur P, Lyman M, Bock R, Momenan R, et al. (2010). Association of mouse DLG4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome. Am J Psychiatry 167: 1508-1517.
8. Freedman R (2003). Schizophrenia. N Engl J Med 349: 1738-1749.
9. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. (2002). The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
10. Garner CC, Nash J, Huganir RL (2000). PDZ domains in synapse assembly and signalling. Trends Cell Biol 10: 274-280.
11. Goff DC, Coyle JT (2001). The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 158: 1367-1377.
12. Harrison PJ, Owen MJ (2003). Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 361: 417-419.
13. Hoggart CJ, Parra EJ, Shriver MD, Bonilla C, Kittles RA, Clayton DG, McKeigue PM (2003). Control of confounding of genetic associations in stratified populations. Am J Hum Genet 72: 1492-1504.
14. Husi H,Ward MA, Choudhary JS, Blackstock WP, Grant SG (2000). Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat Neurosci 3: 661-669.
15. Javitt DC (2010). Glutamatergic theories of schizophrenia. Isr J Psychiatry Relat Sci 47: 4-16.
16. Kawashima R, Ohnuma T, Shibata N, Arai H (2006). No genetic association between postsynaptic density-95 gene polymorphisms and schizophrenia. Neurosci Lett 400: 168-171.
17. Kim E, Sheng M (2004). PDZ domain proteins of synapses. Nat Rev Neurosci 5: 771-781.
18. Kornau HC, Schenker LT, Kennedy MB, Seeburg PH (1995). Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269: 1737-1740.
19. Kristiansen LV, Beneyto M, Haroutunian V, Meador-Woodruff JH (2006). Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia. Mol Psychiatry 11: 737-747, 705.
20. Lou XY, Ma JZ, Sun D, Payne TJ, Li MD (2007). Fine mapping of a linkage region on chromosome 17p13 reveals that GABARAP and DLG4 are associated with vulnerability to nicotine dependence in European-Americans. Hum Mol Genet 16: 142-153.
21. Migaud M, Charlesworth P, Dempster M,Webster LC,Watabe AM, Makhinson M, et al. (1998). Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature 396: 433-439.
22. Ohnuma T, Kato H, Arai H, Faull RL, McKenna PJ, Emson PC (2000). Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia. Neuroreport 11: 3133-3137.
23. Rousset F (2008). Genepop'007: a complete re-implementation of the genepop software for Windows and Linux. Mol Ecol Resour 8: 103-106.
24. Rousset F, Raymond M (1995). Testing heterozygote excess and deficiency. Genetics 140: 1413-1419.
25. Shen Q, Zhang J, Wang Y, Liu B, Li X, Zhao Q, et al. (2011). No association between the KCNH1, KCNJ10 and KCNN3 genes and schizophrenia in the Han Chinese population. Neurosci Lett 487: 61-65.
26. Shi YY, He L (2005). SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15: 97-98.
27. Shim SS, Hammonds MD, Kee BS (2008). Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site. Eur Arch Psychiatry Clin Neurosci 258: 16-27.
28. Stahl SM (2007). Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia. CNS Spectr 12: 265-268.
29. Toro C, Deakin JF (2005). NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder. Schizophr Res 80: 323-330.
30. Tsai SJ, Hong CJ, Cheng CY, Liao DL, Liou YJ (2007). Association study of polymorphisms in post-synaptic density protein 95 (PSD-95) with schizophrenia. J Neural Transm 114: 423-426.
31. Tsuang M (2000). Schizophrenia: genes and environment. Biol Psychiatry 47: 210-220.